Schrodinger

Schrodinger develops a physics-based computational platform used to discover novel molecules for drug development and materials applications, and licenses its software solutions to biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. The company also applies its platform to advance drug discovery programs in collaboration with leading biopharmaceutical companies and to progress its own proprietary drug discovery programs, positioning itself as the leading provider of computational software solutions for drug discovery to the biopharmaceutical industry.

Source: SEC 10-K Feb 25, 2026

Relationship details are part of the Pro plan.